You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 9, September 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Angioedema After Long-term Use of an Angiotensin-Converting Enzyme Inhibitor

MICHAEL R. ABIDIN, MD; DAVID W. EISELE, MD
Baltimore, Md

Arch Otolaryngol Head Neck Surg. 1991;117(9):1059.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—Angiotensin-converting enzyme inhibitors have been regarded as safe medications for the treatment of hypertension. Adverse reactions of these drugs have been minimal except for the recent recognition of angiotensin-converting enzyme inhibitor—associated edema.1,2 The incidence of angioedema with these medications has been estimated to be less than 0.5%.3 There has been recent interest in both the medicine and otolaryngology—head and neck surgery literature concerning this complication. We present a patient who had a delayed episode of angioedema 24 months after the initiation of enalapril.

In March 1991, a 56-year-old woman presented to the emergency department with shortness of breath and inability to handle her secretions. Physical examination revealed edema involving the base of tongue, floor of mouth, and posterior aspect of the pharynx. The patient was treated with intravenous diphenhydramine, subcutaneous heparin, and supplemental oxygen. Emergent fiberoptic endotracheal intubation was performed to secure the patient's . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.